Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Alpha N-Acetylglucosaminidase Market Growth 2022-2028

  • LP 4929034
  • 98 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Alpha N-Acetylglucosaminidase will have significant change from previous year. According to our (LP Information) latest study, the global Alpha N-Acetylglucosaminidase market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Alpha N-Acetylglucosaminidase market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Alpha N-Acetylglucosaminidase market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alpha N-Acetylglucosaminidase market, reaching US$ million by the year 2028. As for the Europe Alpha N-Acetylglucosaminidase landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Alpha N-Acetylglucosaminidase players cover Abeona Therapeutics, Inc., Alexion Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., and Dorphan S.A., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Alpha N-Acetylglucosaminidase market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Lesinidase Alfa

EGT-201

BMN-250

ABO-101

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

In-Patient

Out-Patient

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Abeona Therapeutics, Inc.

Alexion Pharmaceuticals, Inc.

BioMarin Pharmaceutical Inc.

Dorphan S.A.

Laboratorios Del Dr. Esteve S.A.

UniQure N.V.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Alpha N-Acetylglucosaminidase Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Alpha N-Acetylglucosaminidase by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Alpha N-Acetylglucosaminidase by Country/Region, 2017, 2022 & 2028

2.2 Alpha N-Acetylglucosaminidase Segment by Type

2.2.1 Lesinidase Alfa

2.2.2 EGT-201

2.2.3 BMN-250

2.2.4 ABO-101

2.2.5 Others

2.3 Alpha N-Acetylglucosaminidase Sales by Type

2.3.1 Global Alpha N-Acetylglucosaminidase Sales Market Share by Type (2017-2022)

2.3.2 Global Alpha N-Acetylglucosaminidase Revenue and Market Share by Type (2017-2022)

2.3.3 Global Alpha N-Acetylglucosaminidase Sale Price by Type (2017-2022)

2.4 Alpha N-Acetylglucosaminidase Segment by Application

2.4.1 In-Patient

2.4.2 Out-Patient

2.5 Alpha N-Acetylglucosaminidase Sales by Application

2.5.1 Global Alpha N-Acetylglucosaminidase Sale Market Share by Application (2017-2022)

2.5.2 Global Alpha N-Acetylglucosaminidase Revenue and Market Share by Application (2017-2022)

2.5.3 Global Alpha N-Acetylglucosaminidase Sale Price by Application (2017-2022)

3 Global Alpha N-Acetylglucosaminidase by Company

3.1 Global Alpha N-Acetylglucosaminidase Breakdown Data by Company

3.1.1 Global Alpha N-Acetylglucosaminidase Annual Sales by Company (2020-2022)

3.1.2 Global Alpha N-Acetylglucosaminidase Sales Market Share by Company (2020-2022)

3.2 Global Alpha N-Acetylglucosaminidase Annual Revenue by Company (2020-2022)

3.2.1 Global Alpha N-Acetylglucosaminidase Revenue by Company (2020-2022)

3.2.2 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Company (2020-2022)

3.3 Global Alpha N-Acetylglucosaminidase Sale Price by Company

3.4 Key Manufacturers Alpha N-Acetylglucosaminidase Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Alpha N-Acetylglucosaminidase Product Location Distribution

3.4.2 Players Alpha N-Acetylglucosaminidase Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Alpha N-Acetylglucosaminidase by Geographic Region

4.1 World Historic Alpha N-Acetylglucosaminidase Market Size by Geographic Region (2017-2022)

4.1.1 Global Alpha N-Acetylglucosaminidase Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Alpha N-Acetylglucosaminidase Annual Revenue by Geographic Region

4.2 World Historic Alpha N-Acetylglucosaminidase Market Size by Country/Region (2017-2022)

4.2.1 Global Alpha N-Acetylglucosaminidase Annual Sales by Country/Region (2017-2022)

4.2.2 Global Alpha N-Acetylglucosaminidase Annual Revenue by Country/Region

4.3 Americas Alpha N-Acetylglucosaminidase Sales Growth

4.4 APAC Alpha N-Acetylglucosaminidase Sales Growth

4.5 Europe Alpha N-Acetylglucosaminidase Sales Growth

4.6 Middle East & Africa Alpha N-Acetylglucosaminidase Sales Growth

5 Americas

5.1 Americas Alpha N-Acetylglucosaminidase Sales by Country

5.1.1 Americas Alpha N-Acetylglucosaminidase Sales by Country (2017-2022)

5.1.2 Americas Alpha N-Acetylglucosaminidase Revenue by Country (2017-2022)

5.2 Americas Alpha N-Acetylglucosaminidase Sales by Type

5.3 Americas Alpha N-Acetylglucosaminidase Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Alpha N-Acetylglucosaminidase Sales by Region

6.1.1 APAC Alpha N-Acetylglucosaminidase Sales by Region (2017-2022)

6.1.2 APAC Alpha N-Acetylglucosaminidase Revenue by Region (2017-2022)

6.2 APAC Alpha N-Acetylglucosaminidase Sales by Type

6.3 APAC Alpha N-Acetylglucosaminidase Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Alpha N-Acetylglucosaminidase by Country

7.1.1 Europe Alpha N-Acetylglucosaminidase Sales by Country (2017-2022)

7.1.2 Europe Alpha N-Acetylglucosaminidase Revenue by Country (2017-2022)

7.2 Europe Alpha N-Acetylglucosaminidase Sales by Type

7.3 Europe Alpha N-Acetylglucosaminidase Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Alpha N-Acetylglucosaminidase by Country

8.1.1 Middle East & Africa Alpha N-Acetylglucosaminidase Sales by Country (2017-2022)

8.1.2 Middle East & Africa Alpha N-Acetylglucosaminidase Revenue by Country (2017-2022)

8.2 Middle East & Africa Alpha N-Acetylglucosaminidase Sales by Type

8.3 Middle East & Africa Alpha N-Acetylglucosaminidase Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Alpha N-Acetylglucosaminidase

10.3 Manufacturing Process Analysis of Alpha N-Acetylglucosaminidase

10.4 Industry Chain Structure of Alpha N-Acetylglucosaminidase

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Alpha N-Acetylglucosaminidase Distributors

11.3 Alpha N-Acetylglucosaminidase Customer

12 World Forecast Review for Alpha N-Acetylglucosaminidase by Geographic Region

12.1 Global Alpha N-Acetylglucosaminidase Market Size Forecast by Region

12.1.1 Global Alpha N-Acetylglucosaminidase Forecast by Region (2023-2028)

12.1.2 Global Alpha N-Acetylglucosaminidase Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Alpha N-Acetylglucosaminidase Forecast by Type

12.7 Global Alpha N-Acetylglucosaminidase Forecast by Application

13 Key Players Analysis

13.1 Abeona Therapeutics, Inc.

13.1.1 Abeona Therapeutics, Inc. Company Information

13.1.2 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Offered

13.1.3 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abeona Therapeutics, Inc. Main Business Overview

13.1.5 Abeona Therapeutics, Inc. Latest Developments

13.2 Alexion Pharmaceuticals, Inc.

13.2.1 Alexion Pharmaceuticals, Inc. Company Information

13.2.2 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Offered

13.2.3 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Alexion Pharmaceuticals, Inc. Main Business Overview

13.2.5 Alexion Pharmaceuticals, Inc. Latest Developments

13.3 BioMarin Pharmaceutical Inc.

13.3.1 BioMarin Pharmaceutical Inc. Company Information

13.3.2 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Offered

13.3.3 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BioMarin Pharmaceutical Inc. Main Business Overview

13.3.5 BioMarin Pharmaceutical Inc. Latest Developments

13.4 Dorphan S.A.

13.4.1 Dorphan S.A. Company Information

13.4.2 Dorphan S.A. Alpha N-Acetylglucosaminidase Product Offered

13.4.3 Dorphan S.A. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Dorphan S.A. Main Business Overview

13.4.5 Dorphan S.A. Latest Developments

13.5 Laboratorios Del Dr. Esteve S.A.

13.5.1 Laboratorios Del Dr. Esteve S.A. Company Information

13.5.2 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Offered

13.5.3 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Laboratorios Del Dr. Esteve S.A. Main Business Overview

13.5.5 Laboratorios Del Dr. Esteve S.A. Latest Developments

13.6 UniQure N.V.

13.6.1 UniQure N.V. Company Information

13.6.2 UniQure N.V. Alpha N-Acetylglucosaminidase Product Offered

13.6.3 UniQure N.V. Alpha N-Acetylglucosaminidase Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 UniQure N.V. Main Business Overview

13.6.5 UniQure N.V. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Alpha N-Acetylglucosaminidase Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Alpha N-Acetylglucosaminidase Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lesinidase Alfa

Table 4. Major Players of EGT-201

Table 5. Major Players of BMN-250

Table 6. Major Players of ABO-101

Table 7. Major Players of Others

Table 8. Global Alpha N-Acetylglucosaminidase Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Alpha N-Acetylglucosaminidase Sales Market Share by Type (2017-2022)

Table 10. Global Alpha N-Acetylglucosaminidase Revenue by Type (2017-2022) & ($ million)

Table 11. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Type (2017-2022)

Table 12. Global Alpha N-Acetylglucosaminidase Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Alpha N-Acetylglucosaminidase Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Alpha N-Acetylglucosaminidase Sales Market Share by Application (2017-2022)

Table 15. Global Alpha N-Acetylglucosaminidase Revenue by Application (2017-2022)

Table 16. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Application (2017-2022)

Table 17. Global Alpha N-Acetylglucosaminidase Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Alpha N-Acetylglucosaminidase Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Alpha N-Acetylglucosaminidase Sales Market Share by Company (2020-2022)

Table 20. Global Alpha N-Acetylglucosaminidase Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Company (2020-2022)

Table 22. Global Alpha N-Acetylglucosaminidase Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Alpha N-Acetylglucosaminidase Producing Area Distribution and Sales Area

Table 24. Players Alpha N-Acetylglucosaminidase Products Offered

Table 25. Alpha N-Acetylglucosaminidase Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Alpha N-Acetylglucosaminidase Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Alpha N-Acetylglucosaminidase Sales Market Share Geographic Region (2017-2022)

Table 30. Global Alpha N-Acetylglucosaminidase Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Alpha N-Acetylglucosaminidase Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Alpha N-Acetylglucosaminidase Sales Market Share by Country/Region (2017-2022)

Table 34. Global Alpha N-Acetylglucosaminidase Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Alpha N-Acetylglucosaminidase Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Alpha N-Acetylglucosaminidase Sales Market Share by Country (2017-2022)

Table 38. Americas Alpha N-Acetylglucosaminidase Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Alpha N-Acetylglucosaminidase Revenue Market Share by Country (2017-2022)

Table 40. Americas Alpha N-Acetylglucosaminidase Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Alpha N-Acetylglucosaminidase Sales Market Share by Type (2017-2022)

Table 42. Americas Alpha N-Acetylglucosaminidase Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Alpha N-Acetylglucosaminidase Sales Market Share by Application (2017-2022)

Table 44. APAC Alpha N-Acetylglucosaminidase Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Alpha N-Acetylglucosaminidase Sales Market Share by Region (2017-2022)

Table 46. APAC Alpha N-Acetylglucosaminidase Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Alpha N-Acetylglucosaminidase Revenue Market Share by Region (2017-2022)

Table 48. APAC Alpha N-Acetylglucosaminidase Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Alpha N-Acetylglucosaminidase Sales Market Share by Type (2017-2022)

Table 50. APAC Alpha N-Acetylglucosaminidase Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Alpha N-Acetylglucosaminidase Sales Market Share by Application (2017-2022)

Table 52. Europe Alpha N-Acetylglucosaminidase Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Alpha N-Acetylglucosaminidase Sales Market Share by Country (2017-2022)

Table 54. Europe Alpha N-Acetylglucosaminidase Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Alpha N-Acetylglucosaminidase Revenue Market Share by Country (2017-2022)

Table 56. Europe Alpha N-Acetylglucosaminidase Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Alpha N-Acetylglucosaminidase Sales Market Share by Type (2017-2022)

Table 58. Europe Alpha N-Acetylglucosaminidase Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Alpha N-Acetylglucosaminidase Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Alpha N-Acetylglucosaminidase Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Alpha N-Acetylglucosaminidase Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Alpha N-Acetylglucosaminidase Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Alpha N-Acetylglucosaminidase Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Alpha N-Acetylglucosaminidase Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Alpha N-Acetylglucosaminidase Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Alpha N-Acetylglucosaminidase Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Alpha N-Acetylglucosaminidase Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Alpha N-Acetylglucosaminidase

Table 69. Key Market Challenges & Risks of Alpha N-Acetylglucosaminidase

Table 70. Key Industry Trends of Alpha N-Acetylglucosaminidase

Table 71. Alpha N-Acetylglucosaminidase Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Alpha N-Acetylglucosaminidase Distributors List

Table 74. Alpha N-Acetylglucosaminidase Customer List

Table 75. Global Alpha N-Acetylglucosaminidase Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Alpha N-Acetylglucosaminidase Sales Market Forecast by Region

Table 77. Global Alpha N-Acetylglucosaminidase Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Alpha N-Acetylglucosaminidase Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Alpha N-Acetylglucosaminidase Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Alpha N-Acetylglucosaminidase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Alpha N-Acetylglucosaminidase Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Alpha N-Acetylglucosaminidase Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Alpha N-Acetylglucosaminidase Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Alpha N-Acetylglucosaminidase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Alpha N-Acetylglucosaminidase Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Alpha N-Acetylglucosaminidase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Alpha N-Acetylglucosaminidase Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Alpha N-Acetylglucosaminidase Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Alpha N-Acetylglucosaminidase Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Alpha N-Acetylglucosaminidase Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Alpha N-Acetylglucosaminidase Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Alpha N-Acetylglucosaminidase Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Alpha N-Acetylglucosaminidase Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Alpha N-Acetylglucosaminidase Revenue Market Share Forecast by Application (2023-2028)

Table 95. Abeona Therapeutics, Inc. Basic Information, Alpha N-Acetylglucosaminidase Manufacturing Base, Sales Area and Its Competitors

Table 96. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Offered

Table 97. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Abeona Therapeutics, Inc. Main Business

Table 99. Abeona Therapeutics, Inc. Latest Developments

Table 100. Alexion Pharmaceuticals, Inc. Basic Information, Alpha N-Acetylglucosaminidase Manufacturing Base, Sales Area and Its Competitors

Table 101. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Offered

Table 102. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Alexion Pharmaceuticals, Inc. Main Business

Table 104. Alexion Pharmaceuticals, Inc. Latest Developments

Table 105. BioMarin Pharmaceutical Inc. Basic Information, Alpha N-Acetylglucosaminidase Manufacturing Base, Sales Area and Its Competitors

Table 106. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Offered

Table 107. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. BioMarin Pharmaceutical Inc. Main Business

Table 109. BioMarin Pharmaceutical Inc. Latest Developments

Table 110. Dorphan S.A. Basic Information, Alpha N-Acetylglucosaminidase Manufacturing Base, Sales Area and Its Competitors

Table 111. Dorphan S.A. Alpha N-Acetylglucosaminidase Product Offered

Table 112. Dorphan S.A. Alpha N-Acetylglucosaminidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Dorphan S.A. Main Business

Table 114. Dorphan S.A. Latest Developments

Table 115. Laboratorios Del Dr. Esteve S.A. Basic Information, Alpha N-Acetylglucosaminidase Manufacturing Base, Sales Area and Its Competitors

Table 116. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Offered

Table 117. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Laboratorios Del Dr. Esteve S.A. Main Business

Table 119. Laboratorios Del Dr. Esteve S.A. Latest Developments

Table 120. UniQure N.V. Basic Information, Alpha N-Acetylglucosaminidase Manufacturing Base, Sales Area and Its Competitors

Table 121. UniQure N.V. Alpha N-Acetylglucosaminidase Product Offered

Table 122. UniQure N.V. Alpha N-Acetylglucosaminidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. UniQure N.V. Main Business

Table 124. UniQure N.V. Latest Developments

List of Figures

Figure 1. Picture of Alpha N-Acetylglucosaminidase

Figure 2. Alpha N-Acetylglucosaminidase Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Alpha N-Acetylglucosaminidase Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Alpha N-Acetylglucosaminidase Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Alpha N-Acetylglucosaminidase Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lesinidase Alfa

Figure 10. Product Picture of EGT-201

Figure 11. Product Picture of BMN-250

Figure 12. Product Picture of ABO-101

Figure 13. Product Picture of Others

Figure 14. Global Alpha N-Acetylglucosaminidase Sales Market Share by Type in 2021

Figure 15. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Type (2017-2022)

Figure 16. Alpha N-Acetylglucosaminidase Consumed in In-Patient

Figure 17. Global Alpha N-Acetylglucosaminidase Market: In-Patient (2017-2022) & (K Pcs)

Figure 18. Alpha N-Acetylglucosaminidase Consumed in Out-Patient

Figure 19. Global Alpha N-Acetylglucosaminidase Market: Out-Patient (2017-2022) & (K Pcs)

Figure 20. Global Alpha N-Acetylglucosaminidase Sales Market Share by Application (2017-2022)

Figure 21. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Application in 2021

Figure 22. Alpha N-Acetylglucosaminidase Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Company in 2021

Figure 24. Global Alpha N-Acetylglucosaminidase Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Geographic Region in 2021

Figure 26. Global Alpha N-Acetylglucosaminidase Sales Market Share by Region (2017-2022)

Figure 27. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Country/Region in 2021

Figure 28. Americas Alpha N-Acetylglucosaminidase Sales 2017-2022 (K Pcs)

Figure 29. Americas Alpha N-Acetylglucosaminidase Revenue 2017-2022 ($ Millions)

Figure 30. APAC Alpha N-Acetylglucosaminidase Sales 2017-2022 (K Pcs)

Figure 31. APAC Alpha N-Acetylglucosaminidase Revenue 2017-2022 ($ Millions)

Figure 32. Europe Alpha N-Acetylglucosaminidase Sales 2017-2022 (K Pcs)

Figure 33. Europe Alpha N-Acetylglucosaminidase Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Alpha N-Acetylglucosaminidase Sales 2017-2022 (K Pcs)

Figure 35. Middle East & Africa Alpha N-Acetylglucosaminidase Revenue 2017-2022 ($ Millions)

Figure 36. Americas Alpha N-Acetylglucosaminidase Sales Market Share by Country in 2021

Figure 37. Americas Alpha N-Acetylglucosaminidase Revenue Market Share by Country in 2021

Figure 38. United States Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Alpha N-Acetylglucosaminidase Sales Market Share by Region in 2021

Figure 43. APAC Alpha N-Acetylglucosaminidase Revenue Market Share by Regions in 2021

Figure 44. China Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Alpha N-Acetylglucosaminidase Sales Market Share by Country in 2021

Figure 51. Europe Alpha N-Acetylglucosaminidase Revenue Market Share by Country in 2021

Figure 52. Germany Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Alpha N-Acetylglucosaminidase Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Alpha N-Acetylglucosaminidase Revenue Market Share by Country in 2021

Figure 59. Egypt Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Alpha N-Acetylglucosaminidase Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Alpha N-Acetylglucosaminidase in 2021

Figure 65. Manufacturing Process Analysis of Alpha N-Acetylglucosaminidase

Figure 66. Industry Chain Structure of Alpha N-Acetylglucosaminidase

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390